home / stock / bsem / bsem news


BSEM News and Press, BioStem Technologies Inc

Stock Information

Company Name: BioStem Technologies Inc
Stock Symbol: BSEM
Market: OTC
Website: biostemtechnologies.com

Menu

BSEM BSEM Quote BSEM Short BSEM News BSEM Articles BSEM Message Board
Get BSEM Alerts

News, Short Squeeze, Breakout and More Instantly...

BSEM - BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference

POMPANO BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived products for advanced wound care, today announced that Company management wi...

BSEM - BioStem Technologies Highlights Alignment with FDA's Openness to Bayesian Statistical Approaches in Clinical Research

POMPANO BEACH, Fla., Feb. 03, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived products for advanced wound care, today underscored the significance of recent re...

BSEM - BioStem Technologies, Inc. (BSEM) M&A Call Transcript

2026-01-22 10:14:44 ET BioStem Technologies, Inc. (BSEM) M&A Call January 22, 2026 8:00 AM EST Company Participants Philip Taylor - Associate Jason Matuszewski - CEO, President, Secretary & Chairman Barry Hassett - Chief Commercial Officer Brandon Poe...

BSEM - BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings' Surgical and Wound Care Business

Accelerates expansion of BioStem’s commercial organization through integration of an experienced national sales force Expands access to major GPO networks, strengthening BioStem’s position across hospital settings Barry Hassett promoted to Chief Commercial Officer Confer...

BSEM - BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes

Decision ensures continued patient access to VENDAJE ® and VENDAJE AC ® POMPANO BEACH, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived pr...

BSEM - BioStem Technologies Products Placed on "12-Month Status Quo Period" List in Update to CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes

Status Quo designation preserves DFU/VLU reimbursement eligibility for 2026, ensuring continued patient access to BioStem technology Coverage for the majority of BioStem’s non-acute revenue, treatment for pressure ulcers, also remains unaffected by CMS LCD updates    POMPAN...

BSEM - BioStem Technologies® to Debut American Amnion(TM) at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference

POMPANO BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in placental-derived biologics for advanced wound care, today announced the launch of a new product line, American Amnion, at the Desert Foot Multi-Disciplinary Li...

BSEM - BioStem Technologies Expands Product Access in Medicaid

POMPANO BEACH, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in placental-derived biologics for advanced wound care, today announced expanded reimbursement with the inclusion of VENDAJE ® and VENDAJE AC ® i...

BSEM - BioStem Technologies, Inc. (BSEM) Q3 2025 Earnings Call Transcript

2025-11-13 19:51:35 ET BioStem Technologies, Inc. (BSEM) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: BioStem Technologies, Inc. (BSEM) Q3 2025 Earnings Call Transcript

BSEM - BioStem Technologies GAAP EPS of $0.03, revenue of $10.47M

2025-11-13 16:17:55 ET More on BioStem Technologies BioStem Technologies, Inc. (BSEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) Seeking Alpha’s Quant Rating on BioStem Technologies Historical earnings data for BioStem Tec...

Next 10